Henry Brem
CIK: 0001387877
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GALT
GALECTIN THERAPEUTICS INC
Director
Discretionary Trading P&L
Holdings
About Brem Henry
Brem Henry (SEC CIK 0001387877) files insider reports with the SEC as Director of GALECTIN THERAPEUTICS INC (GALT).
Signal8 holds 2 ownership filings by Brem Henry (1 Form 3, 1 Form 4), filed on Mar 17, 2026. Those filings report 1 transaction, the latest on Mar 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Brem Henry's filings is in NORCROSS, GA.
Recent filings by Brem Henry
- Mar 12, 2026: Grant or award of GALT derivative securities (Form 4, code A).
Other insiders filing for GALECTIN THERAPEUTICS INC (GALT)
- Uihlein Richard E, Director
- Jamil Khurram, Chief Medical Officer
- Shlevin Harold H., Director
- ELDRED KARY, Director
- LEWIS JOEL, President and CEO
- CARSON BENJAMIN SR, Director